As Malaysia steers toward becoming a high-income nation, an area that demands urgent and strategic transformation is healthcare. We are witnessing a Malaysian healthcare landscape that is growing in complexity due to an aging population, rising chronic diseases, global supply chain pressures, and digital disruption.
Dato’ Dr Mohd Azman bin Yacob (MOH Medical Development Division Director), Dr. Shamsul Anuar bin Kamarudin (Pengarah Hospital Tunku Azizah), Dr. Ngu Lock Hock (Head of Department of Genetics, Hospital Kuala Lumpur), Nadiah Hanim binti Abdul Latif (President of Malaysian Rare Disorders Society) and Mr. Wong Chin Cheang (Managing Director of Pharm-D Health Science) alongside…
你知道吗？根据吉隆坡中央医院（HKL）遗传学科的数据，截至去年1月，我国卫生部已收治1万3036名罕见疾病儿童。为提升公众对罕见疾病的认识，并为患者提供更多支持，HKL将于2月28日在医院礼堂举办罕见疾病日活动，与全球同步响应国际罕见疾病日。
本次活动将汇聚医疗专家、患者组织及社会各界人士，内容包括专题讲座、互动展示及趣味儿童活动，让参与者深入了解罕见疾病，并与专家交流。诚邀社会各界踊跃参与，共同关怀罕见病群体。
The IDDSI Committee, joined by Chef Preston Walker (1st from left, 2nd row) and Chef James Ball of OHK (1st from right), as well as Ms. Jennifer Wu, representative of Pharm-D (2nd from right). The Asia IDDSI Festival 2024 concluded successfully on 29-30 Nov 2024 at @IMU University, Kuala Lumpur. Organised by the IDDSI Committee under…
A new chapter in healthcare innovation unfolded today as Pharm-D Sdn Bhd joined forces with AGTC Genomics, a leading genomics center specialising in next-generation sequencing (NGS). Two companies formalised a strategic distributorship agreement, signaling a mutual commitment to enhance availability and accessibility of genetic screening to facilitate the advancement of precision medicine in Malaysia. This partnership aims to…
Kuala Lumpur – The Asia IDDSI Festival 2024 is set to take place this year on November 29-30 at IMU University, bringing together healthcare professionals, caregivers, culinary experts, and industry leaders to advance knowledge and practices in dysphagia care. Organised by the International Dysphagia Diet Standardisation Initiative IDDSI Committee, this year’s festival will see Pharm-D Sdn Bhd serving as the…
Kuala Lumpur, Malaysia – The Pharm-D Health Science group of companies, a leading player in the pharmaceutical and nutraceutical industry in Malaysia and Singapore, proudly announces its latest new milestone in its mission to push the boundaries of healthcare innovation, through its biotechnology research and development company Biotenova Sdn Bhd’s latest strategic research partnership with…
Pharm-D Sdn Bhd is proud to announce the launch of Valens Onthera+, a comprehensive immunonutrition supplement drink designed to combat malnutrition in cancer patients. This significant milestone represents years of dedicated research and development, focused on improving patient outcome. Cancer, along with its treatment regimens like chemotherapy and radiotherapy, can often lead to malnutrition. Valens…
The AFPM Annual Scientific Conference by the Academy of Family Physicians of Malaysia wasn’t just about talks, it was about teamwork! This year’s (2024) theme, “Primary Care – For Each and Everyone,” perfectly aligns with Pharm-D’s dedication to patient-centric care. They were joined by fellow pharmaceutical company AiPharma Healthcare Sdn Bhd. Primary care physicians and…
Pharm-D proudly partnered with Monash University Pharmacy Society (MUPhaS) recently to host X-Temp Compounding Workshop for students at the School of Pharmacy at Monash University Malaysia to gain practical experience. X-Temp Oral Suspension, a compounding vehicle by Pharm-D Health Science, is a specialised oral suspension system formulated to assist custom preparation of oral liquid, non-soluble…
Pharm-D Health Science is proud to announce a clinical research collaboration with the esteemed Universiti Sains Malaysia (USM) for a promising clinical study on postbiotics to investigate the effects of postbiotics on gut and immune health, utilising a novel probiotic strain isolated from a locally fermented food origin. This exciting partnership brings together industrial leaders in health science with…
“As an IMU alumnus, collaborating with IMU University in our pharmaceutical pursuits is a genuine honor. The shared commitment to excellence and innovation between Pharm-D and IMU represents our dedicated advancement of healthcare, a partnership which I am particularly proud of,” said Kean Ping Lim, the CEO of Pharm-D Sdn Bhd. 6 March 2024 marks…
